Европейски съюз -
български -
EMA (European Medicines Agency)
lorviqua
pfizer europe ma eeig - lorlatinib - Карцином, недребноклетъчен белодроб - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
Европейски съюз -
български -
EMA (European Medicines Agency)
vizimpro
pfizer europe ma eeig - dacomitinib монохидрат - Карцином, недребноклетъчен белодроб - Антинеопластични средства - vizimpro, като монотерапии, се предписват за първа линия на лечение при възрастни пациенти с локално-разпространена или метастатичен немелкоклеточного рак на белия дроб (НМРЛ) с епидермален фактор на растежа (egfr) спомагателни мутации.
Европейски съюз -
български -
EMA (European Medicines Agency)
vitrakvi
bayer ag - сулфат larotrectinib - Новообразувания На Коремната Кухина - Антинеопластични средства - vitrakvi като монотерапии е предназначен за лечение на възрастни и педиатрични пациенти с твърда тумори, които показват нейротрофический рецептор на тирозин киназы (ntrk) сливане на гени,които имат заболяване, което локално-често, метастазирал или където хирургична резекция може да доведе до тежки заболявания и не са на задоволително лечение.
Европейски съюз -
български -
EMA (European Medicines Agency)
daurismo
pfizer europe ma eeig - glasdegib maleate - Левкемия, миелоиден, остър - Антинеопластични средства - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.
Европейски съюз -
български -
EMA (European Medicines Agency)
insulin aspart sanofi
sanofi winthrop industrie - инсулин аспарт - Захарен диабет - Лекарства, използвани при диабет - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Европейски съюз -
български -
EMA (European Medicines Agency)
sarclisa
sanofi winthrop industrie - isatuximab - Множествена миелома - Антинеопластични средства - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
Европейски съюз -
български -
EMA (European Medicines Agency)
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - Менингит, менингококов - Ваксини - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
Европейски съюз -
български -
EMA (European Medicines Agency)
supemtek
sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - Грип, Човек - Ваксини - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.
Европейски съюз -
български -
EMA (European Medicines Agency)
verquvo
bayer ag - vericiguat - Сърдечна недостатъчност - Сърдечна терапия - treatment of symptomatic chronic heart failure.
